CD58 Expression Does Not Impact Response to Inotuzumab Ozogamicin in Patients with B-cell Acute Lymphoblastic Leukemia
EJHAEM(2025)
Key words
acute leukemia,ALL,CD58,inotuzumab ozogamicin
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined